Marksans Pharma - With Focus On Backward Integration, Margin To Improve: HDFC Securities Initiates Coverage

As inflationary pressures and supply chain disruptions are expected to ease, overall margins could improve.

<div class="paragraphs"><p>Marksans Pharma Ltd.'s corporate office. (Photo: Company website)</p></div>
Marksans Pharma Ltd.'s corporate office. (Photo: Company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More